Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 14 05 2020
accepted: 07 06 2020
pubmed: 5 8 2020
medline: 15 12 2020
entrez: 5 8 2020
Statut: ppublish

Résumé

The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. We explored the rates of emergency presentations for acute coronary syndrome (ACS) and acute cerebrovascular events (ACVE) before and after spread of SARS-CoV-2. We analyzed all-cause visits at a tertiary university emergency department and admissions for ACS and ACVE before (calendar weeks 1-9, 2020) and after (calendar weeks 10-16, 2020) the first coronavirus disease (COVID-19) case in the region of the Saarland, Germany. The data were compared with the same period of the previous year. In 2020 an average of 346 patients per week presented at the emergency department whereas in 2019 an average of 400 patients presented up to calendar week 16 (p = 0.018; whole year 2019 = 395 patients per week). After the first COVID-19 diagnosis in the region, emergency department visit volume decreased by 30% compared with the same period in 2019 (p = 0.0012). Admissions due to ACS decreased by 41% (p = 0.0023 for all; Δ - 71% (p = 0.007) for unstable angina, Δ - 25% (p = 0.42) for myocardial infarction with ST-elevation and Δ - 17% (p = 0.28) without ST-elevation) compared with the same period in 2019 and decreased from 142 patients in calendar weeks 1-9 to 62 patients in calendar weeks 10-16. ACVE decreased numerically by 20% [p = 0.25 for all; transient ischemic attack: Δ - 32% (p = 0.18), ischemic stroke: Δ - 23% (p = 0.48), intracerebral haemorrhage: Δ + 57% (p = 0.4)]. There was no significant change in ACVE per week (p = 0.7) comparing calendar weeks 1-9 (213 patients) and weeks 10-16 (147 patients). Testing of 3756 samples was performed to detect 58 SARS-CoV-2 positive patients (prevalence 1,54%, thereof one patient with myocardial and two with cerebral ischemia) up to calendar week 16 in 2020. The COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.

Sections du résumé

BACKGROUND BACKGROUND
The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. We explored the rates of emergency presentations for acute coronary syndrome (ACS) and acute cerebrovascular events (ACVE) before and after spread of SARS-CoV-2.
METHODS METHODS
We analyzed all-cause visits at a tertiary university emergency department and admissions for ACS and ACVE before (calendar weeks 1-9, 2020) and after (calendar weeks 10-16, 2020) the first coronavirus disease (COVID-19) case in the region of the Saarland, Germany. The data were compared with the same period of the previous year.
RESULTS RESULTS
In 2020 an average of 346 patients per week presented at the emergency department whereas in 2019 an average of 400 patients presented up to calendar week 16 (p = 0.018; whole year 2019 = 395 patients per week). After the first COVID-19 diagnosis in the region, emergency department visit volume decreased by 30% compared with the same period in 2019 (p = 0.0012). Admissions due to ACS decreased by 41% (p = 0.0023 for all; Δ - 71% (p = 0.007) for unstable angina, Δ - 25% (p = 0.42) for myocardial infarction with ST-elevation and Δ - 17% (p = 0.28) without ST-elevation) compared with the same period in 2019 and decreased from 142 patients in calendar weeks 1-9 to 62 patients in calendar weeks 10-16. ACVE decreased numerically by 20% [p = 0.25 for all; transient ischemic attack: Δ - 32% (p = 0.18), ischemic stroke: Δ - 23% (p = 0.48), intracerebral haemorrhage: Δ + 57% (p = 0.4)]. There was no significant change in ACVE per week (p = 0.7) comparing calendar weeks 1-9 (213 patients) and weeks 10-16 (147 patients). Testing of 3756 samples was performed to detect 58 SARS-CoV-2 positive patients (prevalence 1,54%, thereof one patient with myocardial and two with cerebral ischemia) up to calendar week 16 in 2020.
CONCLUSIONS CONCLUSIONS
The COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.

Identifiants

pubmed: 32749557
doi: 10.1007/s00392-020-01688-9
pii: 10.1007/s00392-020-01688-9
pmc: PMC7399595
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1500-1506

Références

World health organization. Coronavirus disease 2019 (COVID-19) situation report: 114. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200501-covid-19-sitrep.pdf?sfvrsn=742f4a18_4 . Accessed 13 May 2020
World health organization. Coronavirus disease (COVID-19) advice for the public. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public . Accessed 13 May 2020
De Filippo O, D'Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G et al (2020) Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. https://doi.org/10.1056/NEJMc2009166 (published online)
doi: 10.1056/NEJMc2009166 pubmed: 32343497 pmcid: 7224608
Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A et al (2020) Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med. https://doi.org/10.1056/NEJMc2010418 (published online)
doi: 10.1056/NEJMc2010418 pubmed: 32348640 pmcid: 7204428
Markus HS, Brainin M (2020) COVID-19 and stroke-A global World Stroke Organization perspective. Int J Stroke. https://doi.org/10.1177/1747493020923472 (published online, 1747493020923472)
doi: 10.1177/1747493020923472 pubmed: 33115386
Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G (2020) Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health 4(5):e10–e11. https://doi.org/10.1016/s2352-4642(20)30108-5
doi: 10.1016/s2352-4642(20)30108-5 pubmed: 32278365 pmcid: 7146704
Custodis F, Schwarzkopf K, Weimann R, Spüntrup E, Böhm M, Laufs U (2020) A SARS-Cov2-negative corona victim. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01668-z
doi: 10.1007/s00392-020-01668-z pubmed: 32388581 pmcid: 7210796
Robert Koch Institut. COVID-19 (Coronavirus SARS-CoV-2). 2020. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html . Accessed 10 May 2020
Lohse S, Pfuhl T, Berkó-Göttel B, Rissland J, Geißler T, Gärtner B, Becker SL, Schneitler S et al (2020) Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30362-5
doi: 10.1016/S1473-3099(20)30362-5 pubmed: 32679086 pmcid: 7194818
Krumholz HM (2020) Where have all the heart attacks gone? The New York Times https://www.nytimes.com/2020/04/06/well/live/coronavirus-doctors-hospitals-emergency-care-heart-attack-stroke.html . Accessed 1 May 2020
Thornton J (2020) Covid-19: A and E visits in England fall by 25% in week after lockdown. BMJ 369:m1401. https://doi.org/10.1136/bmj.m1401
doi: 10.1136/bmj.m1401 pubmed: 32253175
Mohammad MA, Karlsson S, Haddad J, Cederberg B, Jernberg T, Lindahl B, Fröbert O, Koul S et al (2018) Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998–2013. BMJ 363:k4811. https://doi.org/10.1136/bmj.k4811
doi: 10.1136/bmj.k4811 pubmed: 30541902 pmcid: 6289164
Eindhoven DC, Wu HW, Kremer SWF, van Erkelens JA, Cannegieter SC, Schalij MJ, Borleffs CJW (2018) Mortality differences in acute myocardial infarction patients in the Netherlands: the weekend-effect. Am Heart J 205:70–76. https://doi.org/10.1016/j.ahj.2018.07.015
doi: 10.1016/j.ahj.2018.07.015 pubmed: 30176441
Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ (2020) Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa314
doi: 10.1093/eurheartj/ehaa314 pubmed: 32297932 pmcid: 7184486
Abdi S, Salarifar M, Mortazavi SH, Sadeghipour P, Geraiely B (2020) COVID-19 sends STEMI to quarantine!? Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01664-3 (published online)
doi: 10.1007/s00392-020-01664-3 pubmed: 32436055 pmcid: 7238393
Böhm M Frey N Giannitsis E Sliwa K Zeiher A (2020) Coronavirus disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol (published online)
Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ et al (2020) Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 75(22):2871–2872. https://doi.org/10.1016/j.jacc.2020.04.011
doi: 10.1016/j.jacc.2020.04.011 pubmed: 32283124 pmcid: 7151384
Hornig CR, Dorndorf W, Agnoli AL (1986) Hemorrhagic cerebral infarction–a prospective study. Stroke 17(2):179–185. https://doi.org/10.1161/01.str.17.2.179
doi: 10.1161/01.str.17.2.179 pubmed: 3515635
Campbell AM (2020) An increasing risk of family violence during the Covid-19 pandemic: strengthening community collaborations to save lives. Forensic Sci Int Rep 2:100089. https://doi.org/10.1016/j.fsir.2020.100089
doi: 10.1016/j.fsir.2020.100089
Sakaniwa R, Tromp J, Shirai K, Yamagishi K, Tamakoshi A, Iso H (2020) The association of conventionally medicated systolic and diastolic blood pressure level and mortality from cardiovascular disease: is the lower the better in high stroke population? Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01587-8 (published online)
doi: 10.1007/s00392-019-01587-8 pubmed: 31950253
Meredith PA (1996) Therapeutic implications of drug “holidays’. Eur Heart J. https://doi.org/10.1093/eurheartj/17.suppl_a.21 (17 Suppl A)
doi: 10.1093/eurheartj/17.suppl_a.21 pubmed: 8737197
Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.013 (published online)
doi: 10.1016/j.thromres.2020.04.013 pubmed: 33049599 pmcid: 7544592
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418. https://doi.org/10.1016/s0140-6736(20)30937-5 (published online)
doi: 10.1016/s0140-6736(20)30937-5 pubmed: 7172722 pmcid: 7172722
Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M et al (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. https://doi.org/10.1093/cvr/cvaa106 (published online)
doi: 10.1093/cvr/cvaa106 pubmed: 32980876 pmcid: 7526753
Hinterseer M, Zens M, Wimmer RJ, Delladio S, Lederle S, Kupatt C, Hartmann B (2020) Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01663-4
doi: 10.1007/s00392-020-01663-4 pubmed: 32430631 pmcid: 7235975

Auteurs

Viktoria Schwarz (V)

Emergency Department, Saarland University Medical Center, Homburg, Germany. viktoria.schwarz@uks.eu.
Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany. viktoria.schwarz@uks.eu.

Felix Mahfoud (F)

Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany.

Lucas Lauder (L)

Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany.

Wolfgang Reith (W)

Department of Neuroradiology, Saarland University Medical Center, Homburg, Germany.

Stefanie Behnke (S)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Sigrun Smola (S)

Institute of Virology, Saarland University Medical Center, Homburg, Germany.

Jürgen Rissland (J)

Institute of Virology, Saarland University Medical Center, Homburg, Germany.

Thorsten Pfuhl (T)

Institute of Virology, Saarland University Medical Center, Homburg, Germany.

Bruno Scheller (B)

Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany.

Michael Böhm (M)

Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany.

Sebastian Ewen (S)

Emergency Department, Saarland University Medical Center, Homburg, Germany. Sebastian.Ewen@uks.eu.
Clinic of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, Geb. 41, 66421, Homburg, Saar, Germany. Sebastian.Ewen@uks.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH